205 related articles for article (PubMed ID: 22848163)
1. Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells.
Matsuo H; Yoshimoto N; Iijima M; Niimi T; Jung J; Jeong SY; Choi EK; Sewaki T; Arakawa T; Kuroda S
Int J Nanomedicine; 2012; 7():3341-50. PubMed ID: 22848163
[TBL] [Abstract][Full Text] [Related]
2. CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cells.
Matsuo H; Somiya M; Iijima M; Arakawa T; Kuroda S
J Nanobiotechnology; 2018 Aug; 16(1):59. PubMed ID: 30077180
[TBL] [Abstract][Full Text] [Related]
3. Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.
Tatematsu K; Iijima M; Yoshimoto N; Nakai T; Okajima T; Kuroda S
Acta Biomater; 2016 Apr; 35():238-47. PubMed ID: 26876802
[TBL] [Abstract][Full Text] [Related]
4. A bio-nanocapsule containing envelope protein domain III of Japanese encephalitis virus protects mice against lethal Japanese encephalitis virus infection.
Miyata T; Tafuku S; Harakuni T; Tadano M; Yoshimoto N; Iijima M; Matsuo H; Matsuzaki G; Kuroda S; Arakawa T
Microbiol Immunol; 2013 Jun; 57(6):470-7. PubMed ID: 23773026
[TBL] [Abstract][Full Text] [Related]
5. Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.
Jung J; Iijima M; Yoshimoto N; Sasaki M; Niimi T; Tatematsu K; Jeong SY; Choi EK; Tanizawa K; Kuroda S
Protein Expr Purif; 2011 Aug; 78(2):149-55. PubMed ID: 21515381
[TBL] [Abstract][Full Text] [Related]
6. Nanocapsules incorporating IgG Fc-binding domain derived from Staphylococcus aureus protein A for displaying IgGs on immunosensor chips.
Iijima M; Kadoya H; Hatahira S; Hiramatsu S; Jung G; Martin A; Quinn J; Jung J; Jeong SY; Choi EK; Arakawa T; Hinako F; Kusunoki M; Yoshimoto N; Niimi T; Tanizawa K; Kuroda S
Biomaterials; 2011 Feb; 32(6):1455-64. PubMed ID: 21106232
[TBL] [Abstract][Full Text] [Related]
7. Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery.
Li H; Tatematsu K; Somiya M; Iijima M; Kuroda S
Acta Biomater; 2018 Jun; 73():412-423. PubMed ID: 29673839
[TBL] [Abstract][Full Text] [Related]
8. Bionanocapsule-based enzyme-antibody conjugates for enzyme-linked immunosorbent assay.
Iijima M; Matsuzaki T; Kadoya H; Hatahira S; Hiramatsu S; Jung G; Tanizawa K; Kuroda S
Anal Biochem; 2010 Jan; 396(2):257-61. PubMed ID: 19819216
[TBL] [Abstract][Full Text] [Related]
9. Oriented immobilization to nanoparticles enhanced the therapeutic efficacy of antibody drugs.
Iijima M; Araki K; Liu Q; Somiya M; Kuroda S
Acta Biomater; 2019 Mar; 86():373-380. PubMed ID: 30641288
[TBL] [Abstract][Full Text] [Related]
10. Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.
Somiya M; Sasaki Y; Matsuzaki T; Liu Q; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
J Control Release; 2015 Aug; 212():10-8. PubMed ID: 26074149
[TBL] [Abstract][Full Text] [Related]
11. Fluorophore-labeled nanocapsules displaying IgG Fc-binding domains for the simultaneous detection of multiple antigens.
Iijima M; Matsuzaki T; Yoshimoto N; Niimi T; Tanizawa K; Kuroda S
Biomaterials; 2011 Dec; 32(34):9011-20. PubMed ID: 21864900
[TBL] [Abstract][Full Text] [Related]
12. Nano-visualization of oriented-immobilized IgGs on immunosensors by high-speed atomic force microscopy.
Iijima M; Somiya M; Yoshimoto N; Niimi T; Kuroda S
Sci Rep; 2012; 2():790. PubMed ID: 23145314
[TBL] [Abstract][Full Text] [Related]
13. Bio-nanocapsules for oriented immobilization of DNA aptamers on aptasensors.
Iijima M; Yamada Y; Nakano H; Nakayama T; Kuroda S
Analyst; 2022 Jan; 147(3):489-495. PubMed ID: 35023508
[TBL] [Abstract][Full Text] [Related]
14. Development of bionanocapsules targeting brain tumors.
Tsutsui Y; Tomizawa K; Nagita M; Michiue H; Nishiki T; Ohmori I; Seno M; Matsui H
J Control Release; 2007 Sep; 122(2):159-64. PubMed ID: 17692421
[TBL] [Abstract][Full Text] [Related]
15. Low immunogenic bio-nanocapsule based on hepatitis B virus escape mutants.
Jung J; Somiya M; Jeong SY; Choi EK; Kuroda S
Nanomedicine; 2018 Feb; 14(2):595-600. PubMed ID: 29175598
[TBL] [Abstract][Full Text] [Related]
16. Two-dimensional membrane scaffold for the oriented immobilization of biosensing molecules.
Iijima M; Nakayama T; Kuroda S
Biosens Bioelectron; 2020 Feb; 150():111860. PubMed ID: 31735623
[TBL] [Abstract][Full Text] [Related]
17. Nanocapsule-based probe for evaluating the orientation of antibodies immobilized on a solid phase.
Iijima M; Yoshimoto N; Niimi T; Maturana AD; Kuroda S
Analyst; 2013 Jun; 138(12):3470-7. PubMed ID: 23653905
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.
Yamada M; Oeda A; Jung J; Iijima M; Yoshimoto N; Niimi T; Jeong SY; Choi EK; Tanizawa K; Kuroda S
J Control Release; 2012 Jun; 160(2):322-9. PubMed ID: 22100387
[TBL] [Abstract][Full Text] [Related]
19. Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.
Liu Q; Jung J; Somiya M; Iijima M; Yoshimoto N; Niimi T; Maturana AD; Shin SH; Jeong SY; Choi EK; Kuroda S
Int J Nanomedicine; 2015; 10():4159-72. PubMed ID: 26203243
[TBL] [Abstract][Full Text] [Related]
20. Anchoring antibodies to membranes using a diphtheria toxin T domain-ZZ fusion protein as a pH sensitive membrane anchor.
Nizard P; Liger D; Gaillard C; Gillet D
FEBS Lett; 1998 Aug; 433(1-2):83-8. PubMed ID: 9738938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
